Evidence map›Paper›PMID 35953447›Full record

ArticleBrain : a journal of neurology2022

Variants in the zinc transporter TMEM163 cause a hypomyelinating leukodystrophy.

Michelle C do Rosario, Guillermo Rodriguez Bey, Bruce Nmezi, Fang Liu, Talia Oranburg, Ana S A Cohen, Keith A Coffman, Maya R Brown, Kirill Kiselyov, Quinten Waisfisz and 8 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Loss of the endoplasmic reticulum protein Tmem208 affects cell polarity, development, and viability.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Michelle C do RosarioDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
Guillermo Rodriguez BeyDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Bruce NmeziDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Fang LiuDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Talia OranburgDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ana S A CohenGenomic Medicine Center, Children's Mercy, Kansas City, MO 64108, USA.
Keith A CoffmanDivision of Neurology, Movement Disorders Clinic, Tourette Syndrome Center of Excellence, Children's Mercy Hospital, Kansas City, Missouri, USA.ORCID 0000-0003-2474-7857
Maya R BrownDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kirill KiselyovDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Quinten WaisfiszDepartment of Human Genetics, Amsterdam University Medical Centers, VU University Amsterdam, and Amsterdam Neuroscience, Amsterdam, The Netherlands.
Myrthe T FlohilDepartment of Neurology, Noordwest ziekenhuisgroep, Wilhelminalaan Alkmaar, The Netherlands.
Shahyan SiddiquiDepartment of Neuroimaging and Interventional Radiology, STAR Institute of Neurosciences, STAR Hospitals, Hyderabad, India.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-5664-7987
Alejandro IglesiasDepartment of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
Katta Mohan GirishaDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
Nicole I WolfAmsterdam UMC Location Vrije Universiteit Amsterdam, Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma's Children's Hospital, and Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands.ORCID 0000-0003-1721-0728
Quasar Saleem PadiathDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Anju ShuklaDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.ORCID 0000-0003-2471-4094
University of Pittsburgh · USManipal Academy of Higher Education · INAmsterdam Neuroscience · NLChildren's Mercy Hospital · USBaylor College of Medicine · USColumbia University Irving Medical Center · USNoordwest Ziekenhuisgroep · NL

Funding

Genetic Diagnosis of Neurodevelopmental Disorders in IndiaR01HD093570 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIELAS, STEPHANIE LEE · 2018 to 2024
$2.3M
Elucidating mechanisms involved in Lamin B1 mediated demyelinationR01NS095884 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PADIATH, QUASAR S · 2016 to 2020
$2.1M
High-content screening for modulators of lamin B1 as a therapeutic target in autosomal dominant leukodystrophyR33NS106087 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PADIATH, QUASAR S, VOGT, ANDREAS · 2019 to 2020
$783k
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant LeukodystrophyR33NS104384 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PADIATH, QUASAR S · 2020 to 2021
$748k
National Institutes of Health, USA 1R01HD093570-01A1NICHD NIH HHS R01 HD093570NINDS NIH HHS R01 NS095884NINDS NIH HHS R33 NS104384NINDS NIH HHS R33 NS106087
6 · The paper itself

Abstract

Hypomyelinating leukodystrophies comprise a subclass of genetic disorders with deficient myelination of the CNS white matter. Here we report four unrelated families with a hypomyelinating leukodystrophy phenotype harbouring variants in TMEM163 (NM_030923.5). The initial clinical presentation resembled Pelizaeus-Merzbacher disease with congenital nystagmus, hypotonia, delayed global development and neuroimaging findings suggestive of significant and diffuse hypomyelination. Genomic testing identified three distinct heterozygous missense variants in TMEM163 with two unrelated individuals sharing the same de novo variant. TMEM163 is highly expressed in the CNS particularly in newly myelinating oligodendrocytes and was recently revealed to function as a zinc efflux transporter. All the variants identified lie in highly conserved residues in the cytoplasmic domain of the protein, and functional in vitro analysis of the mutant protein demonstrated significant impairment in the ability to efflux zinc out of the cell. Expression of the mutant proteins in an oligodendroglial cell line resulted in substantially reduced mRNA expression of key myelin genes, reduced branching and increased cell death. Our findings indicate that variants in TMEM163 cause a hypomyelinating leukodystrophy and uncover a novel role for zinc homeostasis in oligodendrocyte development and myelin formation.

Indexed as

Pelizaeus-Merzbacher DiseaseCarrier ProteinsHumansMembrane ProteinsMutation, MissenseMyelin SheathZincCarrier ProteinsMembrane ProteinsTMEM163 protein, humanZinczinc-binding proteingenomic testinghypomyelinating leukodystrophiesoligodendrocytesTMEM163

Identifiers

PMID35953447
PMCPMC10200305
OpenAlexW4290973691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.